Picture of Innoviva logo

INVA — Innoviva News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeMid CapContrarian

Brief: Innoviva Specialty Therapeutics Signs Exclusive Distribution And Licensing Agreement To Acquire U.S. Marketing Rights For Zevtera®

Dec 16 (Reuters) - Innoviva Inc  INVA.O :
    * INNOVIVA SPECIALTY THERAPEUTICS SIGNS EXCLUSIVE
DISTRIBUTION AND
LICENSING AGREEMENT TO ACQUIRE U.S. MARKETING RIGHTS FOR
ZEVTERA® (CEFTOBIPROLE)
    * INNOVIVA INC: UNDER TERMS OF AGREEMENT, INNOVIVA, INC.,
WILL BE
GRANTED EXCLUSIVE MARKETING RIGHTS TO ZEVTERA IN U.S.
    * INNOVIVA INC: UNDER AGREEMENT TERMS, BASILEA WILL RECEIVE
$4
MILLION UPFRONT PAYMENT IN ADDITION TO TIERED ROYALTIES AND
MILESTONES ON NET SALES IN U.S.
    * INNOVIVA INC: INNOVIVA SPECIALTY THERAPEUTICS ANTICIPATES
COMMERCIALIZING ZEVTERA IN MID-YEAR 2025

Source text:  ID:nBw1q3cFLa 
Further company coverage:  INVA.O

Recent news on Innoviva

See all news